|
Status |
Public on Dec 03, 2014 |
Title |
Sample_MD_B1_mic_pre0 |
Sample type |
SRA |
|
|
Source name |
Primary new-born derived microglia treated with TGFb1
|
Organism |
Mus musculus |
Characteristics |
strain: C57BL/6 organ: Primary microglia culture selection marker: Time following TGFb1 treatment treatment: TGFb1 treatment time: time 0
|
Treatment protocol |
TGFb1 (100ng/ml) was added to the cells
|
Growth protocol |
Extrected from new-born primary glial culture
|
Extracted molecule |
total RNA |
Extraction protocol |
miRNeasy (Qiagen) see Jaitin et. al., Science 2014
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 1500 |
|
|
Description |
TGFB_RAW.xlsx
|
Data processing |
Illumina Casava1.8 software used for basecalling. alignment: tophat with deafult parameters Expression table done using ESAT http://garberlab.umassmed.edu/software/esat/ Genome_build: mm9 Supplementary_files_format_and_content: tab-delimited text files include mRNA molecule count values for each Sample
|
|
|
Submission date |
Oct 24, 2014 |
Last update date |
May 15, 2019 |
Contact name |
Ido Amit |
E-mail(s) |
ido.amit@weizmann.ac.il
|
Phone |
972-8-9343338
|
Organization name |
Weizmann Institute of Science
|
Department |
Immunology
|
Street address |
234 Herzl st.
|
City |
Rehovot |
ZIP/Postal code |
760001 |
Country |
Israel |
|
|
Platform ID |
GPL18480 |
Series (1) |
GSE62698 |
Spinal cord injury (RNA sequencing data) |
|
Relations |
BioSample |
SAMN03142864 |
SRA |
SRX742766 |